On December 3, 2020, Cosnine Co., Ltd. (KOSDAQ:A082660) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,840 KRW | -0.16% | -1.18% | -11.96% |
1st Jan change | Capi. | |
---|---|---|
-11.96% | 50.21M | |
+0.74% | 261B | |
+18.31% | 20.69B | |
0.00% | 18.4B | |
+9.50% | 11.56B | |
-10.06% | 9.69B | |
+17.79% | 7.66B | |
+14.08% | 6.19B | |
+2.13% | 4.62B | |
-15.27% | 3.91B |
- Stock Market
- Equities
- A175250 Stock
- News Icure Pharmaceutical Incorporation
- Cosnine Co., Ltd. announced that it has received KRW 4 billion in funding from Icure Pharmaceutical Incorporation and another investor